Compare Davita Inc (DVA) vs Yum China Holdings Inc (YUMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Yum China Holdings Inc — how do they compare? Davita Inc trades at $179.12 (market cap $11.38B), while Yum China Holdings Inc trades at $47.63 (market cap $16.28B). The key difference: Yum China Holdings Inc is the larger of the two by market cap, and Yum China Holdings Inc pays a 2.44% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | YUMC | |
|---|---|---|
Market Cap | $11.38B | $16.28B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $57.95 |
52-Week Low | $103.87 | $40.18 |
Enterprise Value | $24.10B | $17.19B |
Dividend Yield | — | 2.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
YUMC trades at $48.19, up 0.98% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. The company reported revenue of $11.80B in 2025 with a net income margin of 7.84%, and recently completed the acquisition of the Pizza Hut brand in Mainland China, enhancing strategic control. Analyst consensus is strongly positive with 14 buy ratings and a projected 26.21% upside potential.
The outlook for YUMC is favorable due to consistent earnings growth, store expansion, and the Pizza Hut acquisition eliminating royalty fees. Risks include macroeconomic headwinds in China and competitive pressures. Wall Street sentiment remains bullish, supported by institutional confidence and positive earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Yum China Holdings Inc
With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →
